Evidence map›Paper›PMID 38596656›Full record

ArticleExperimental and therapeutic medicine2024

Control of pleural effusion with prednisolone in a patient with yellow nail syndrome: A case report.

Manato Taguchi, Hironori Masuko, Kai Kawashima, Tetsuya Yamagishi, Yuka Kitaoka, Rie Shigemasa, Kazufumi Yoshida, Chikako Tsurushige, Hiroaki Satoh, Nobuyuki Hizawa

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Experimental and therapeutic medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Manato TaguchiDepartment of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Hironori MasukoDepartment of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Kai KawashimaDepartment of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Tetsuya YamagishiDepartment of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Yuka KitaokaDepartment of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Rie ShigemasaDepartment of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Kazufumi YoshidaDepartment of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Chikako TsurushigeDepartment of Respiratory Medicine, Moriya Daiichi General Hospital, Moriya, Ibaraki 302-0102, Japan.
Hiroaki SatohDivision of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Ibaraki 310-0015, Japan.
Nobuyuki HizawaDepartment of Pulmonary Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
University of Tsukuba · JPNational Hospital Organization Mito Medical Center · JPOgori Daiichi General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yellow nail syndrome (YNS) can induce bilateral exudative pleural effusion; however, to the best of our knowledge, no standard treatment for YNS has been established. The present study describes a patient with YNS for whom the pleural effusion was controlled by prednisolone. A 73-year-old man was referred to the University of Tsukuba Hospital (Ibaraki, Japan) complaining of shortness of breath, which was diagnosed as being due to bilateral pleural effusion. Based on the presence of yellowing and growth retardation of the toenails, lymphedema, bilateral exudative pleural fluid of unknown etiology, and lymphatic congestion on lymphoscintigraphy, the patient was diagnosed with YNS. The pleural fluid was predominantly lymphocytic and responded to systemic steroid administration [prednisolone 30 mg/day (0.5 mg/kg) for 2 weeks, with subsequent weekly tapering]. The general condition of the patient and their dyspnea also improved with treatment. These findings indicated that systemic steroid administration should be considered as one of the treatment options for patients with YNS who are reluctant to undergo chest drainage or pleurodesis due to the potential for a decrease in their ability to perform daily activities and respiratory function.

Indexed as

corticosteroidlymphedemapleural fluidyellow nail syndrome

Identifiers

PMID38596656
PMCPMC11002817
OpenAlexW4393083433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.